성신화학

비상장계속사업자

Sung Shin Chemical Co.,Ltd.

김권진

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

성신화학

Business Reg. No. 1238158686 · CEO 김권진

I.Investment Overview

Target성신화학 (1238158686)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명성신화학
영문명Sung Shin Chemical Co.,Ltd.
대표자김권진
사업자등록번호1238158686
법인등록번호1351110053309
설립일2000.07.07
종업원수68명

V.Workforce

68

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW233.22021207.82022192.32023218.22024168.82025
영업이익100M KRW5.52021-6.52022-8.32023-11.220240.82025
순이익100M KRW3.82021-8.52022-7.82023-12.620240.22025
Item20252024202320222021
자산총계175억원154.4억원150.4억원157.1억원139.1억원
부채총계107.2억원117.6억원101억원99.9억원101.4억원
자본총계67.8억원36.8억원49.4억원57.2억원37.8억원
매출액168.8억원218.2억원192.3억원207.8억원233.2억원
영업이익8,305만원-11.2억원-8.3억원-6.5억원5.5억원
순이익2,187만원-12.6억원-7.8억원-8.5억원3.8억원

VII.Financial Ratios

FY2025 basis

0.49%

영업이익률

0.13%

순이익률

0.12%

ROA

0.32%

ROE

158.24%

부채비율

38.72%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

성신화학 투심보고서 | Alpha Lenz